Maisonneuve-Rosemont Hospital gets $50M for new cancer centre
New centre to offer immunotherapy, a less invasive way to treat cancer
The Maisonneuve-Rosemont Hospital will soon be home to a new $50 million cancer treatment centre.
The hospital, which is affiliated with the Université de Montréal, presented its draft plan to build the centre on Thursday.
- 'Game changer': BC cancer agency opens immunotherapy lab in Victoria
- Canadian researcher says immunotherapy is a cancer-fighting miracle
The centre will specialize in immunotherapy, a relatively new method of treating cancer that is less invasive than chemotherapy and radiotherapy. Immunotherapy uses medications that cause a person's immune system to attack cancerous cells.
The centre received funding from both the federal and provincial government, as well as 40 private sector sponsors.
$800,000 for treatment in United States
The creation of the centre is welcome news for Laval resident Matthew Schreindorfer, who was diagnosed with leukemia in 2014.
He paid more than $800,000 for immunotherapy treatment in the United States. Afterwards, he was briefly declared cancer-free, but months later, doctors once again found cancerous cells in his bone marrow.
- Matthew Schreindorfer announces he's now cancer-free
- Matthew Schreindorfer says cancer cells are back
His friends and family crowdsourced the money for his treatment.
"We pushed a lot," he said. "We did a lot of awareness on Facebook and elsewhere. We're really happy to be here. This is excellent news for Montreal, Quebec and for Canada as a whole."
Quebec Health Minister Gaétan Barrette attended the hospital's announcement, and said he welcomes the centre.
"Understand that this centre is not only a production centre, but also a centre for research, processing and marketing," he said.